RKI-1447
RKI-1447 is a potent small molecule inhibitor of ROCK1 and ROCK2 with IC50 values of 14.5 nM and 6.2 nM, respectively.
Product Specifications
CAS Number
1342278-01-6
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
ROCK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rki-1447.html
Concentration
10mM
Purity
98.02
Solubility
DMSO : ≥ 50 mg/mL
Smiles
O=C(NC1=NC(C2=CC=NC=C2)=CS1)NCC3=CC=CC(O)=C3
Molecular Formula
C16H14N4O2S
Molecular Weight
326.37
Precautions
H302, H315, H319
References & Citations
[1]Patel RA, et al. RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer. Cancer Res. 2012 Oct 1;72 (19) :5025-34.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ROCK1; ROCK2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400008-100 1x 100 µL
MAGE A1 (MA454), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400225-500 1x 500 µL
Major Vault Protein (MVP) (1032), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400780-100 1x 100 µL
HSP60 (HSPD1/780), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680859-500 1x 500 µL
Human Kappa Light Chain (Kap-56), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882397-100 1x 100 µL
CD14 (Monocyte / Macrophage Marker) (LPSR/2397), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 